State of Health In EU: Community Pharmacy Contribution

Similar documents
State of Health In EU: Community Pharmacy Contribution

European Community Pharmacy: a reference in Public Health

Alcohol-related harm in Europe and the WHO policy response

Introduction to the Global AMR Action Plan

European status report on alcohol and health Leadership, awareness and commitment

The cancer burden in the European Union and the European Region: the current situation and a way forward

Where we stand in EFORT

European Status report on Alcohol and Health

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Smokefree Policies in Europe: Are we there yet?

Summary. Primary care data. Week 49/2014. Season

Q1 What age are you?

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Engagement in language assessment / Regions of Europe

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Development of Palliative Care services in different countries

Prevention of Oral Cancer Special Interest Working Group

European Association of Dental Public Health Prevention of Oral Cancer

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

LEBANON. WCPT COUNTRY PROFILE December 2018

Better Health for All in Latvia

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Measles and rubella monitoring January 2015

DENMARK. WCPT COUNTRY PROFILE December 2018

Key issues for HIV testing and

Alcohol Prevention Day

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

GERMANY. WCPT COUNTRY PROFILE December 2018

Overview of drug-induced deaths in Europe - What does the data tell us?

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

Information about activities in the region of possible relevance for the regional strategic plan. GF-TADs for Europe

Real Life, Real PD Survey

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Pharmacy Ownership and Establishment

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

The challenge of obesity in the WHO European Region

Access to treatment and disease burden

Underage drinking in Europe

Inequality in injury risks

Monthly measles and rubella monitoring report

Where do EU Contries set the limit for low risk drinking.

COMMISSION OF THE EUROPEAN COMMUNITIES

The health economic landscape of cancer in Europe

Cardiovascular disease in Europe: epidemiological update 2016

Seventh GF-TADs for Europe Steering Committee meeting (RSC7)

WHO initiatives to build global AMR surveillance capacity

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Cross Border Genetic Testing for Rare Diseases

The Identification of Food Safety Priorities using the Delphi Technique

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Table 6.1 Summary information for colorectal cancer in Ireland,

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

Overall survival: 1 st line therapy

Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States

Best practices in collecting and processing data in CRC screening and after it

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

Table 9.1 Summary information for stomach cancer in Ireland,

Budapest, Hungary, September 2017 xx July xxx. Progress reports

EUVAC.NET A surveillance network for vaccine-preventable diseases

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Primary and secondary prevention of sudden cardiac death in emerging economies

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

This document is a preview generated by EVS

European Collaboration on Dementia. Luxembourg, 13 December 2006

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Transmission, processing and publication of HBS 2015 data

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

HPAI H5(N8) in Member States in poultry, captive and wild birds

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

Transcription:

State of Health In EU: Community Pharmacy Contribution #PGEUSoH www.pgeu.eu

SYLVAIN GIRAUD DG SANTE #PGEUSoH

GAÉTAN LAFORTUNE OECD #PGEUSoH

CHALLENGES TO EU HEALTH SYSTEMS EMBARGOED UNTIL PUBLICATION OF HEALTH AT A GLANCE 2016 Gaétan Lafortune, OECD Health Division European Parliament, Brussels, 15 November 2016

HANNE BAK PEDERSEN WHO

State of health in the EU: the Community Pharmacy Contribution - vis a vis Antimicrobial Resistance Hanne Bak Pedersen Programme Manager, WHO Regional Office for Europe PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Presentation outline Antimicrobiel resistance current situation and WHO action The role of the pharmacist related to AMR The role of the pharmacists and health care PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Awareness Week PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

European strategic action plan on antibiotic resistance (2011 2020) WHO European action plan adopted by all 53 Member States Recognizing AMR neglected in many countries of the region No systematic AMR surveillance in large part of the Region Need for intersectoral coordination International spread through travel and trade Need for international standards and data sharing PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Action Plan Strategic Objectives 1. Strengthen intersectoral coordination 2. Strengthen surveillance of antibiotic resistance 3. Promote rational use and strengthen surveillance of antibiotic consumption 4. Strengthen infection prevention and control and surveillance in health care settings 5. Prevent emerging resistance in veterinary and food sectors 6. Promote innovation and research on new drugs 7. Improve awareness, patient safety, and partnership PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Implementation of action plan WHO Europe has a specific focus on supporting non-eu Member States as ECDC supports EU member states National intersectoral coordination Development of national action plans Surveillance on antibiotic consumption and resistance for evidence-based action Advocacy and awareness raising For example through country assessments, national and subregional workshops, training, twinning, consultancies PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Implementation activities (2012-2016) Country situation analysis Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Georgia, Kazakhstan, Kyrgyzstan, Kosovo, Moldova, Russia, Serbia, Tajikistan, Turkey, Turkmenistan, Ukraine, Uzbekistan National AMR workshops Albania, Armenia, Bosnia and Herzegovina, Belarus, Bulgaria, The former Yugoslav Republic of Macedonia, Georgia, Moldova, Serbia, Tajikistan, Turkey, Uzbekistan International AMR workshops on regular basis to create awareness and share experience and best practices PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Surveillance in European Union Antimicrobial Resistance 1998 EARSS 2010 EARS-Net Antimicrobial Consumption 2001 ESAC 2011 ESAC-Net PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Surveillance in European region Antimicrobial Resistance 2012 CAESAR Antimicrobial Consumption 2011 AMC Network PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Expanding AMR surveillance throughout Europe European Antimicrobial Resistance Surveillance Network (EARS-Net) Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) European Centre for Disease Prevention and Control World Health Organization Regional Office for Europe Countries submitting data to CAESAR Countries building capacity for CAESAR participation Countries invited for CAESAR participation Countries participating in EARS-Net PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Expanding AMC / use surveillance throughout Europe European Surveillance of Antimicrobial Consumption Network (ESAC-Net) WHO Antimicrobial Medicines Consumption network (AMC) European Centre for Disease Prevention and Control World Health Organization Regional Office for Europe Countries which reported 2013 data to WHO Countries in the process of collecting AMC data Countries participating in ESAC-Net PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Expanding AMC / use surveillance throughout Europe Lancet Infectious Diseases 2014 Published Online, March 20, 2014 http://dx.doi.org/10.1016/s1473-3099(14)70071-4 PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Expanding AM use surveillance throughout Europe Use methodology compatible with ESAC-Net Enable data comparison in the European Region 4-fold difference in antibiotic use across the European Region Lancet Infectious Diseases 2014 Published Online, March 20, 2014 http://dx.doi.org/10.1016/s1473-3099(14)70071-4 PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

The role of the pharmacist related to AMR In 2014 Who Europe published a review of the policy and guidance in Europe in relation to the community pharmacy/pharmacist and the results of a survey investigating and mapping current roles that the pharmacist perform along with potentials for strengthening AMR-related action http://www.euro.who.int/en/health-topics/health-systems/health-technologies-andmedicines/publications/2014/the-role-of-pharmacist-in-encouraging-prudent-use-of-antibiotic-medicines-andaverting-antimicrobial-resistance-a-review-of-current-policies-and-experiences-in-europe-2014 PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Good Pharmacy Practices GPP guidelines were chosen as the framework of analysis Prepare, obtain, store, secure, dispense and dispose of medical products Provide effective medication therapy management Maintain and improve professional performance Contribute to improving effectiveness of the health care system and public health PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Countries where OTC sales of antibiotics are legal PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Countries where it is possible to buy antibiotics online without prescription PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Authorities responsible for the development of guidelines on antibiotic treatment (total= 44) More can be done to guard against overuse of antibiotics Pharmacist can be Antibiotic Guardians PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Calls to Action - Pharmacists: Only dispense antibiotics when they are needed, according to current guidelines (e.g. check the patient has a valid prescription, for the right drug/dose/duration) When patients are seeking treatment for cold or flu, explain that antibiotics are not needed Talk to patients about how to take antibiotics correctly, antibiotic resistance & the dangers of misuse Remind patients to contact their health professional if symptoms persist or they experience side effects Talk to patients about preventing infections (e.g. vaccination, hand washing, safer sex, covering nose & mouth when sneezing) PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

AMR Partnership Nobody is exempt from the problem nor from playing a part in the solution" PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Pharmacists and health care Potential expanded roles for the community pharmacists: ensuring the effective, safe, and efficient use of medicines Address adherence to current regulation of use of antibiotics eg dispensing, guideline adherence etc Increase level of and quality of information on use and disposal of medicines Increase collaboration with other health professionals for more responsible use of medicines Patient information - eg infection prevention and control Promoting chronic disease prevention and management - Medication review, chronic care coordination, blood pressure measurement, smoke cessation, salt reduction, dietary advice, repeat prescription Take a role in vaccination programmes Take a role in screening & treatment of minor ailments PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

If you want to know more World Antibiotic Awareness Week: http://who.int/campaigns/world-antibiotic-awareness-week/en/ Access to new medicines in Europe: Please consult our website: http://www.euro.who.int/en/health-topics/health-systems/healthtechnologies-and-medicines http://www.euro.who.int/en/health-topics/health-systems/medicines/publications2/2015/access-to-newmedicines-in-europe-technical-review-of-policy-initiatives-and-opportunities-for-collaboration-andresearch pedersenh@who.int PGEU State of Health in EU: the Community Pharmacy Contribution mtg. 15 Nov. 2016

Community Pharmacy Contribution to EU Health Systems Darragh O Loughlin IPU Secretary General PGEU Immediate Past President darragh.oloughlin@ipu.ie @Darragh_OL 15/11/2016 State of Health in the EU: Community Pharmacy Contribution #PGEUSoH www.pgeu.eu

Pharmaceutical Group of European Union Members: Professional Bodies & Pharmacists Associations 2016: 33 Countries At the hearth of European communities #PGEUSoH Austria Belgium Bulgaria Croatia Cyprus Czech Rep Denmark Estonia Finland France Germany Greece Hungary Ireland Italy Luxembourg Malta Netherlands Poland Portugal Romania Slovakia Slovenia Spain Sweden United Kingdom Bosnia Herzegovina FYR Macedonia Norway Serbia Switzerland Turkey Ukraine

1959 2016 400.000 Community Pharmacists 160.000 Pharmacies 46 million citizens visit a pharmacy every day At the hearth of European communities #PGEUSoH

Average length of stay in community care If you want health, have a HEALTH system: Changing the Agendum by Joachim Sturmberg European Journal for Person Centered Healthcare 2015 Vol 3 Issue 2 pp 175-181 At the hearth of European communities #PGEUSoH

Distribution of medicines in Europe 120.0% Channel distribution 2015 100.0% 6.2% 80.0% 35.7% 60.0% 40.0% 20.0% 64.3% 93.8% 0.0% Value Volume (based on standard units) Retail Hospital IMS data based on the country selection: Austria, Belgium, Bulgaria, Croatia, Czech, Finland, France, Germany, Hungary, Ireland, Italy, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden, Switzerland, UK. At the hearth of European communities #PGEUSoH

Distance and equity At the hearth of European communities #PGEUSoH

At the heart of communities At the hearth of European communities

Responding to Change Pharmacy practice has transformed from focusing only on medicines and disease to patient care and quality Large portion of total health care spending is on pharmaceuticals and chronic diseases, imperative to improve healthcare quality and personal outcomes Pharmacy services aim to achieve the triple aim : Better quality of care Better health outcome Lower costs At the hearth of European communities

It all makes sense More trips here can mean fewer visits here At the hearth of European communities #PGEUSoH

Trends in pharmacy services Core Pharmacy Services (expertise in medicines): Dispensing (incl. repeat dispensing and homecare); Compounding; Medication management (unit dose packaging, new medicines service, medicines use review); Emergency care (incl. emergency contraception) and minor ailment management. Advanced Pharmacy Services (health care services): Vaccination; Smoking cessation; Measurement of blood pressure, cholesterol, glucose, weight, Chronic disease management; Early screening and testing. At the hearth of European communities #PGEUSoH

Overview of Pharmacy Services Additional pharmacy services by number of country Dispensing prescriptions Disposal of medicines waste Weight measurement Blood pressure measurement Emergency Contraception Glucose measurement Smoking Cessation Cholesterol measurement Provision of information to patients on conditions/treatments Diabetes management Repeat dispensing Asthma management Medicines Use Review Hypertension management Homecare services New medicines services Pregnancy test Vaccination *PGEU Database 2014-15 25 25 23 22 22 20 20 19 17 15 15 14 14 14 13 11 11 9 0 5 10 15 20 25 30 At the hearth of European communities #PGEUSoH

Ex.: Examples #PGEUSoH

Medicines Use Review Available in a pharmacy in 14 European countries. Aims to: improve patients understanding of their medicines; highlight problematic side effects and propose solutions where appropriate; improve adherence and reduce medicines wastage. At the hearth of European communities #PGEUSoH

Medicines Use Review Structured adherence-centred review by a pharmacist with a polymedicated patient The pharmacist reviews the patient s use of medication, ensuring they understand how the medicines should be used and why they have been prescribed, identifying any problems and then, where necessary, providing feedback to the prescriber. It is intended particularly for those receiving medicines for long-term conditions. National target groups (high risk) are agreed in order to guide the selection of patients to whom the service is offered. At the hearth of European communities #PGEUSoH

New Medicine Service Available in a pharmacy in 11 European countries. The service provides support for people with long-term conditions newly prescribed a medicine. It aims to improve medicines adherence and patient outcomes (patients most likely to discontinue treatment in first month or two National target groups (high risk) are normally agreed in order to guide the selection of patients to whom the service is offered. At the hearth of European communities #PGEUSoH

New Medicine Service New Medicine Service aims to help a patient: to find out more about the new medicine he has been prescribed to sort out any problems he may have with his new medicine gives a chance to ask questions about his medicine and discuss any concerns to improve the effectiveness of a new medicine to make their own decisions about managing his condition to improve their health, which could lead to fewer GP and hospital visits. At the hearth of European communities #PGEUSoH

Emergency care All pharmacies in Europe offer: Minor ailment (cough, sore throat, head lice, indigestion, flu, etc.) management, Emergency supply for chronic and acute conditions. At the hearth of European communities #PGEUSoH

Health Checks in a Pharmacy One can measure blood pressure in 22 countries weight in 23 countries blood glucose levels in 20 countries cholesterol in 20 countries in a community pharmacy. At the hearth of European communities #PGEUSoH

Disease Management Programmes Disease management programs aim to provide holistic and personalised care to individuals with certain (often chronic) conditions: Diabetes management programmes are available in pharmacies in 15 countries; Asthma management programmes are available in pharmacies in 14 countries; Hypertension management programmes are available in pharmacies in 14 countries. At the hearth of European communities

Public Health Services in a Pharmacy In 20 European countries pharmacies offer smoking cessation services; Pharmacies support number of national and regional public health campaigns: Including European Antibiotic Awareness Day; As part of our daily practice we offer health and wellbeing advice and support for self care At the hearth of European communities #PGEUSoH

Vaccination In 9 countries in Europe pharmacists contribute to a significant advancement towards the EU target of vaccinating 75% of at risk groups against influenza; At the hearth of European communities #PGEUSoH

ehealth Since the beginning of pharmacy computerisation in the early 90s community pharmacy developed the necessary infrastructure and culture to implement innovation in such a way as to efficiently deliver significant benefits to the public. Today 100% of pharmacies are computerized, majority has a broadband connection. In 17 countries pharmacies can dispense eprescriptions. However, we still struggle to get access to patient ehealth records. Committed to establishment and management of European Medicines Verification System with other supply chain actors and governments. Together with our patients we are learning to use apps. At the hearth of European communities 50 #PGEUSoH

What is next for community pharmacy? The case for the pharmacist s contribution to health systems in the form of services, has never been stronger; Evidence confirms that pharmacists interventions not only improve patient outcomes, they also save money; However, services are unlikely to be sustainable on a large scale without funder support; Our accessibility is the major asset, and needs to be preserved along with logistic efficiency ; New services are important, but the dispensing function is crucial to our place in communities; Quality, professionalism and added value are at the heart of what we do. At the hearth of European communities #PGEUSoH

Vision...future where services offered at European community pharmacies, at the heart of the communities by highly qualified and independent healthcare professionals community pharmacists - further support individual patients, public health and the healthcare system. /European Community Pharmacy Blueprint 2012/ At the hearth of European communities #PGEUSoH

THANK YOU! Pharmaceutical Group of the European Union (PGEU) Rue du Luxembourg 19, 1000 Brussels, Belgium +32 (0)2 238 08 18 pharmacy@pgeu.eu www.pgeu.eu #PGEUSoH